secwatch.observer — SEC 8-K summary
======================================

Issuer:     Odyssey Health, Inc. (ODYY)
CIK:        0001626644
Form:       8-K
Filed at:   2022-11-01T23:59:59+00:00
Accession:  0001683168-22-007168
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 8.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Odyssey Health files patent for intranasal brain-drug device; Phase I study successful
--------------------------------------------------------------------------------

- Filed US/global patent for breath-propelled intranasal brain-drug delivery device (Nasal Device).
- Phase I study of PRV-002 concussion drug via Nasal Device completed; well-tolerated in 40 healthy volunteers.
- No Nasal Device failures documented; device deposits drug deep into nasal cavity for direct CNS diffusion.
- CEO Michael Redmond cited advantage of direct brain delivery with fewer side effects for neurological treatments.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1626644/000168316822007168/0001683168-22-007168-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1626644/000168316822007168/odyssey_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-22-007168

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer